Founder
CurrentCenSyn is a pre-FDA stage medical device platform used for comprehensive brain health tracking & management. The company creates a handheld EEG brain monitoring device and an AI platform to analyze critical brain data to accelerate screening of conditions such as seizures, strokes and concussions. The platform is currently under testing to be used in emergency departments, Intensive Care Units, Sideline athletic concussion screening, ambulance & primary care settings. As a founder, I focus on operations, technology development, FDA strategy, early-stage customer acquisition and creating a clinician network for early device adoption.[Technical]: develop biosignal acquisition chip to acquire EEG signals from patients and transmit wirelessly to a phone application. Focus on AFE & digital processor design/fabrication, AI web platform/application development, mechanical/electrical interface integration, IEC 80601 & clinical usability workflow testing.